{
  "image_filename": "table_p3_det_2_009.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/table_p3_det_2_009.png",
  "image_type": "Table",
  "page_number": 3,
  "block_id": "det_2_009",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Table listing solicited systemic adverse events by severity (mild, moderate, severe) for FluBlok (N=2344) versus Placebo (N=2304), including events such as fever, fatigue, shivering, joint pain, muscle pain, headache, nausea, pain, and bruising with counts and percentages. does not support the claim because the table shows comparisons between FluBlok and placebo only; there is no mention of Fluarix or a Flublok versus Fluarix comparison. Note: Image is clear for safety data but no comparator other than placebo is shown.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table listing solicited systemic adverse events by severity (mild, moderate, severe) for FluBlok (N=2344) versus Placebo (N=2304), including events such as fever, fatigue, shivering, joint pain, muscle pain, headache, nausea, pain, and bruising with counts and percentages.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table shows comparisons between FluBlok and placebo only; there is no mention of Fluarix or a Flublok versus Fluarix comparison.",
    "confidence_notes": "Image is clear for safety data but no comparator other than placebo is shown."
  }
}